Drug Shortage Report for DELATESTRYL
Report ID | 176956 |
Drug Identification Number | 00029246 |
Brand name | DELATESTRYL |
Common or Proper name | DELATESTRYL |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | TESTOSTERONE ENANTHATE |
Strength(s) | 200MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
Packaging size | 5ml |
ATC code | G03BA |
ATC description | ANDROGENS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2022-11-21 |
Estimated end date | 2022-12-09 |
Actual end date | 2022-12-07 |
Shortage status | Resolved |
Updated date | 2022-12-21 |
Company comments | waiting QA release |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2022-12-21 | French | Compare |
v6 | 2022-12-21 | English | Compare |
v5 | 2022-12-07 | French | Compare |
v3 | 2022-12-07 | English | Compare |
v4 | 2022-12-07 | English | Compare |
v2 | 2022-12-02 | French | Compare |
v1 | 2022-12-02 | English | Compare |
Showing 1 to 7 of 7